DACH Open-angle Glaucoma Market
授權報價
| Single User License | $4,950 USD |
| Enterprise License | $5,950 USD |
| Corporate User License | $7,950 USD |
完整報告名稱與涵蓋範圍
DACH Open-angle Glaucoma Market Size, Share & Trends Analysis Report By Product (Schlemm’s Canal-Based Devices, Subconjunctival Devices), By Procedure (Bleb-based Procedure, Non-bleb-based Procedure), By Type, By End-use, By Country, And Segment Forecasts, 2026 - 2033
報告摘要
DACH Open-angle Glaucoma Market Summary
The DACH open-angle glaucoma market size was valued at USD 53.2 million in 2025 and is projected to grow from USD 56.7 million in 2026 to USD 91.8 million by 2033, at a CAGR of 7.1% from 2026 to 2033. The rapidly aging population across the DACH region is one of the primary factors driving the increasing prevalence of open-angle glaucoma (OAG). As a chronic age-related optic neuropathy, primary open-angle glaucoma (POAG) predominantly affects older adults, with disease incidence and prevalence increasing substantially after the age of 60.
The demographic transition toward an older population across the DACH (Germany, Austria, and Switzerland) countries is therefore expanding the number of individuals at risk of developing glaucoma, creating sustained demand for early diagnosis, long-term disease management, and advanced glaucoma treatment technologies. Germany, Austria, and Switzerland are countries with the highest life expectancy and a steadily growing elderly population. Improvements in healthcare infrastructure, disease prevention, and overall living standards have contributed to increased longevity, resulting in a larger proportion of individuals aged 65 years and older. While these demographic changes reflect positive healthcare outcomes, they also contribute to a growing burden of chronic ophthalmic disorders, particularly glaucoma, which remains one of the leading causes of irreversible blindness among older adults. Consequently, healthcare providers across the DACH region are witnessing a gradual increase in glaucoma-related outpatient consultations, diagnostic evaluations, and long-term follow-up requirements.
The aging demographic also supports higher utilization of ophthalmology services throughout the region. Older adults are more likely to undergo routine comprehensive eye examinations, optical coherence tomography (OCT), visual field testing, optic nerve imaging, and intraocular pressure monitoring, leading to improved identification of glaucoma cases. As awareness of preventive eye care continues to increase and healthcare systems emphasize early detection of vision-threatening diseases, demand for glaucoma screening and diagnostic services is expected to rise steadily across the region.
Glaucoma societies across the DACH region play a central role in advancing clinical practice, research collaboration, and awareness related to open-angle glaucoma. Regional and national organizations support the development of standardized treatment guidelines, promote continuing medical education, and facilitate knowledge exchange among ophthalmologists. These societies also contribute to early detection initiatives, patient education programs, and advocacy efforts aimed at reducing glaucoma-related vision loss. In addition, they often collaborate with healthcare institutions, regulatory bodies, and industry stakeholders to encourage the adoption of advanced diagnostic and therapeutic approaches.
DACH Open-angle Glaucoma Market Report Segmentation
This report forecasts revenue & volume growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the DACH open-angle glaucoma market report based on product, procedure, type, end use, and country:
• Product Outlook (Volume, Units; Revenue, USD Million, 2021 - 2033)
• Schlemm’s Canal-Based Devices
• Subconjunctival Devices
• Procedure Outlook (Volume, Units; Revenue, USD Million, 2021 - 2033)
• Bleb-based Procedure
o Perforating (Fistulizing) Bleb-based Procedures
o Non-Perforating Bleb-based Procedures (NPDS)
• Non-bleb-based Procedure
• Type Outlook (Volume, Units; Revenue, USD Million, 2021 - 2033)
• Standalone
• Combined
• End Use Outlook (Volume, Units; Revenue, USD Million, 2021 - 2033)
• Inpatient
• Outpatient
• Country Outlook (Volume, Units; Revenue, USD Million, 2021 - 2033)
• Germany
• Austria
• Switzerland
目錄 Table of Contents
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Procedure
1.2.3. Type
1.2.4. End Use
1.2.5. Country scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Procedure outlook
2.2.3. Type outlook
2.2.4. End Use outlook
2.2.5. Country outlook
2.3. Competitive Insights
Chapter 3. DACH Open Angle Glaucoma Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. DACH Open Angle Glaucoma Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. DACH Open Angle Glaucoma Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. DACH Open Angle Glaucoma Market: Product Movement Analysis
4.3. DACH Open Angle Glaucoma Market by Product Outlook (USD Million, Volume in Units)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Schlemm’s Canal-Based Devices
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
4.6. Subconjunctival Devices
4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
Chapter 5. DACH Open Angle Glaucoma Market: Procedure Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. DACH Open Angle Glaucoma Market: Procedure Movement Analysis
5.3. DACH Open Angle Glaucoma Market by Procedure Outlook (USD Million, Volume in Units)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Bleb-based Procedure
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
5.5.2. Perforating (Fistulizing) Bleb-based Procedures
5.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
5.5.3. Non-Perforating Bleb-based Procedures (NPDS)
5.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
5.6. Non-bleb-based Procedure
5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
Chapter 6. DACH Open Angle Glaucoma Market: Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. DACH Open Angle Glaucoma Market: Type Movement Analysis
6.3. DACH Open Angle Glaucoma Market by Type Outlook (USD Million, Volume in Units)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Standalone
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
6.6. Combined
6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
Chapter 7. DACH Open Angle Glaucoma Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. DACH Open Angle Glaucoma Market: End Use Movement Analysis
7.3. DACH Open Angle Glaucoma Market by End Use Outlook (USD Million, Volume in Units)
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.5. Inpatient
7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
7.6. Outpatient
7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
Chapter 8. DACH Open Angle Glaucoma Market: Country Estimates & Trend Analysis
8.1. Country Dashboard
8.2. Country DACH Open Angle Glaucoma Market Movement Analysis
8.3. DACH Open Angle Glaucoma Market: Regional Estimates & Trend Analysis by Product & Procedure
8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
8.5. DACH
8.5.1. DACH Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
8.5.2. Germany
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement scenario
8.5.2.5. Germany Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
8.5.3. Austria
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement scenario
8.5.3.5. Austria Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
8.5.4. Switzerland
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Reimbursement scenario
8.5.4.5. Switzerland Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in Units)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Key Company Profiles
9.2.1. AbbVie Inc.
9.2.1.1. Company Overview
9.2.1.2. Financial Performance
9.2.1.3. Product Benchmarking
9.2.1.4. Strategic Initiatives
9.2.2. Santen Pharmaceutical Co., Ltd.
9.2.2.1. Company Overview
9.2.2.2. Financial Performance
9.2.2.3. Product Benchmarking
9.2.2.4. Strategic Initiatives
9.2.3. Glaukos Corporation
9.2.3.1. Company Overview
9.2.3.2. Financial Performance
9.2.3.3. Product Benchmarking
9.2.3.4. Strategic Initiatives
9.2.4. Alcon Inc.
9.2.4.1. Company Overview
9.2.4.2. Financial Performance
9.2.4.3. Product Benchmarking
9.2.4.4. Strategic Initiatives
9.2.5. Sight Sciences, Inc.
9.2.5.1. Company Overview
9.2.5.2. Financial Performance
9.2.5.3. Product Benchmarking
9.2.5.4. Strategic Initiatives
9.2.6. MicroSurgical Technology
9.2.6.1. Company Overview
9.2.6.2. Financial Performance
9.2.6.3. Product Benchmarking
9.2.6.4. Strategic Initiatives
9.2.7. New World Medical
9.2.7.1. Company Overview
9.2.7.2. Financial Performance
9.2.7.3. Product Benchmarking
9.2.7.4. Strategic Initiatives
圖表清單 List of Tables & Figures
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. DACH open angle glaucoma market, by country, 2021 - 2033 (USD Million, Volume in Units)
Table 4. DACH open angle glaucoma market, by product, 2021 - 2033 (USD Million, Volume in Units)
Table 5. DACH open angle glaucoma market, by procedure, 2021 - 2033 (USD Million, Volume in Units)
Table 6. DACH open angle glaucoma market, by type, 2021 - 2033 (USD Million, Volume in Units)
Table 7. DACH open angle glaucoma market, by end use, 2021 - 2033 (USD Million, Volume in Units)
Table 8. Germany open angle glaucoma market, by product, 2021 - 2033 (USD Million, Volume in Units)
Table 9. Germany open angle glaucoma market, by procedure, 2021 - 2033 (USD Million, Volume in Units)
Table 10. Germany open angle glaucoma market, by type, 2021 - 2033 (USD Million, Volume in Units)
Table 11. Germany open angle glaucoma market, by end use, 2021 - 2033 (USD Million, Volume in Units)
Table 12. Austria open angle glaucoma market, by product, 2021 - 2033 (USD Million, Volume in Units)
Table 13. Austria open angle glaucoma market, by procedure, 2021 - 2033 (USD Million, Volume in Units)
Table 14. Austria open angle glaucoma market, by type, 2021 - 2033 (USD Million, Volume in Units)
Table 15. Austria open angle glaucoma market, by end use, 2021 - 2033 (USD Million, Volume in Units)
Table 16. Switzerland open angle glaucoma market, by product, 2021 - 2033 (USD Million, Volume in Units)
Table 17. Switzerland open angle glaucoma market, by procedure, 2021 - 2033 (USD Million, Volume in Units)
Table 18. Switzerland open angle glaucoma market, by type, 2021 - 2033 (USD Million, Volume in Units)
Table 19. Switzerland open angle glaucoma market, by end use, 2021 - 2033 (USD Million, Volume in Units)
List of Figures
Fig 1. DACH open angle glaucoma market segmentation
Fig 2. Market research process
Fig 3. Data triangulation techniques
Fig 4. Primary research pattern
Fig 5. Market research approaches
Fig 6. Value-chain-based sizing & forecasting
Fig 7. Market formulation & validation
Fig 8. Market snapshot
Fig 9. Product and procedure outlook (USD Million)
Fig 10. End use outlook (USD Million)
Fig 11. Competitive landscape
Fig 12. DACH open angle glaucoma market dynamics
Fig 13. DACH open angle glaucoma market: Porter’s five forces analysis
Fig 14. DACH open angle glaucoma market: PESTLE analysis
Fig 15. DACH open angle glaucoma market: Product segment dashboard
Fig 16. DACH open angle glaucoma market: Product market share analysis, 2025 & 2033
Fig 17. Schlemm’s canal-based devices market, 2021 - 2033 (USD Million, Volume in Units)
Fig 18. Subconjunctival devices market, 2021 - 2033 (USD Million, Volume in Units)
Fig 19. DACH open angle glaucoma market: Procedure segment dashboard
Fig 20. DACH open angle glaucoma market: Procedure market share analysis, 2025 & 2033
Fig 21. Bleb-based procedure market, 2021 - 2033 (USD Million, Volume in Units)
Fig 22. Perforating (fistulizing) bleb-based procedures market, 2021 - 2033 (USD Million, Volume in Units)
Fig 23. Non-perforating bleb-based procedures (NPDS) market, 2021 - 2033 (USD Million, Volume in Units)
Fig 24. Non-bleb-based procedure market, 2021 - 2033 (USD Million, Volume in Units)
Fig 25. DACH open angle glaucoma market: Type segment dashboard
Fig 26. DACH open angle glaucoma market: Type market share analysis, 2025 & 2033
Fig 27. Standalone market, 2021 - 2033 (USD Million, Volume in Units)
Fig 28. Combined market, 2021 - 2033 (USD Million, Volume in Units)
Fig 29. DACH open angle glaucoma market: End use segment dashboard
Fig 30. DACH open angle glaucoma y market: End use market share analysis, 2025 & 2033
Fig 31. Inpatient market, 2021 - 2033 (USD Million, Volume in Units)
Fig 32. Outpatient market, 2021 - 2033 (USD Million, Volume in Units)
Fig 33. DACH open angle glaucoma market revenue, by country
Fig 34. Country marketplace: Key takeaways
Fig 35. DACH open angle glaucoma market, 2021 - 2033 (USD Million, Volume in Units)
Fig 36. Germany country dynamics
Fig 37. Germany open angle glaucoma market, 2021 - 2033 (USD Million, Volume in Units)
Fig 38. Austria country dynamics
Fig 39. Austria open angle glaucoma market, 2021 - 2033 (USD Million, Volume in Units)
Fig 40. Switzerland country dynamics
Fig 41. Switzerland open angle glaucoma market, 2021 - 2033 (USD Million, Volume in Units)
Fig 42. Company categorization
Fig 43. Company market position analysis
Fig 44. Strategic framework
提及公司
同分類最新報告（醫療器材）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們